Under the global pandemic of COVID-19,point-of-care testing(POCT)strategy as a fast,simple,and low-cost biological detection method has drawn much attention for achieving accurate on-site testing[1].
基金supported by the National Key R&D Program of China(2023YFE0111500 and 2023YFC3040900)the National Natural Science Foundation of China(52222313,22075296,52321006,T2394480,T2394484 and 52203247)+2 种基金the China Postdoctoral Science Foundation(2022TQ0340)Beijing National Laboratory for Molecular Sciences(BNLMS-CXXM-202005)Junior Fellow Program of Beijing National Laboratory for Molecular Sciences(2021BMS20063)。
基金supported by the Beijing Nova Program from Beijing Municipal Science&Technology Commission(Z201100006820037,Z211100002121001)the National Key Research and Development Program of China(2018YFA0208501)+2 种基金the National Natural Science Foundation of China(22075296,91963212,and 51961145102)the Youth Innovation Promotion Association of CAS(2020032)Beijing National Laboratory for Molecular Sciences(CXXM-202005)。
文摘Under the global pandemic of COVID-19,point-of-care testing(POCT)strategy as a fast,simple,and low-cost biological detection method has drawn much attention for achieving accurate on-site testing[1].
